Business Context and Reporting Period
Perdoceo Education Corporation (PRDO) filed a Current Report on Form 8-K dated July 15, 2024. The filing announces the entry into a definitive Merger Agreement to acquire University of St. Augustine Parent Corp. (USAPC), the indirect owner of the University of St. Augustine for Health Sciences (USAHS). USAHS is a leading provider of graduate health sciences degrees with campuses in California, Florida, and Texas, as well as online programs.
Key Financial Metrics and Transaction Terms
- Target Financials (USAHS FY2023): Approximately $170 million in revenue and $35 million in operating income.
- Target Enrollment: Approximately 4,500 graduate and post-graduate students (FY2023).
- Purchase Price: Expected aggregate cash consideration of $142 million to $144 million, subject to working capital, cash, and debt adjustments.
- Funding Source: Fully funded using Perdoceo's available cash balances.
- Termination Fees: Potential fees of $4 million, $10 million, or $20 million payable by Perdoceo under specific termination scenarios.
- Insurance: Perdoceo is purchasing a buyer-side representation and warranty insurance policy as the primary recourse for breaches.
Material Changes and Outlook
This filing represents a material change in Perdoceo's business strategy through a significant acquisition. Management reaffirmed its full-year adjusted operating income outlook of $175 million to $190 million, stating the company remains on track to achieve this target despite the pending transaction.
Closing Timeline: The transaction is expected to close in December 2024. If not closed by December 2024, the purchase price range may adjust. The agreement may be terminated if the closing does not occur by April 1, 2025, with an automatic extension possible to July 1, 2025 under specific regulatory delay circumstances.
Risks, Contingencies, and Unusual Items
- Regulatory Approvals: Closing is contingent on receiving educational agency consents and a preacquisition review response from the U.S. Department of Education.
- Antitrust Review: Subject to the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
- Integration Risks: Risks include the inability to achieve anticipated benefits, the acquired business underperforming, and disruptions to current operations.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to various uncertainties.
Investor Verification Checklist
- Verify the final purchase price adjustments based on the closing balance sheet for cash, debt, and working capital.
- Monitor the status of the U.S. Department of Education preacquisition review and other required educational consents.
- Confirm the impact of the $142–$144 million cash outlay on Perdoceo's remaining liquidity and debt covenants.
- Review the full text of the Merger Agreement (Exhibit 2.1) for specific representations, warranties, and termination conditions.
- Assess the integration plan and potential synergies between Perdoceo's existing portfolio and USAHS's health sciences programs.